September 2025

135 Articles

No Section

Publisher's note

1 September 2025
Author(s):

Within the publishing industry, article numbering has emerged as an easy and efficient way to cite journal articles. Article numbering has already been successfully rolled out to Elsevier's... more

Differences in indications, contraindications, and prescribing patterns for heart failure between specialties: the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry

27 August 2025
Author(s): Jason A Gencher, Samaneh Salimian, Ricky D Turgeon, Penny Tam, Nathaniel M Hawkins, VOCAL-AHF study group

Heart failure (HF) is a major public health challenge affecting over 64 million adults worldwide and a leading cause of hospitalization [1]. Despite therapeutic advances, the prognosis remains poor,... more

Renal outcomes following anticoagulation in atrial fibrillation: urgent need for randomized evidence

25 August 2025
Author(s): Costas Platanias, Ioannis Vasileiadis, Ilektra Oikonomopoulou, Elias Sanidas, Costas Thomopoulos

We read with interest the well-written meta-analysis by Adamou et al. [1], focused on studies of atrial fibrillation (AF) patients, investigating the comparative effect of direct oral anticoagulants... more

Diagnostic contribution of minor salivary glands biopsy in clinical practice

16 May 2025
Author(s): Marion Mauclin, Anh-Tuan Nguyen, Hubert Nielly, Hélène Vanquaethem, Weniko Caré

Dear Editor,

Clinical Insights

New perspectives on heart-brain interactions: Is it time to classify cardio-neurological syndromes?

23 August 2025
Author(s): Camilla Grifoni, Paolo Fucini, Iacopo Olivotto

The interplay between heart and brain is bi-directional, complex and profound. Each system influences the other in health as well as in disease, when dysfunction in one organ has broad and as yet... more

Stroke prevention in atrial fibrillation patients with end-stage renal disease: how far from Ithaca after a long Odyssey?

8 August 2025
Author(s): Davide Antonio Mei, Francesco Tritto, Jacopo Francesco Imberti, Marco Vitolo, Giuseppe Boriani

Atrial fibrillation (AF) and chronic kidney disease (CKD) are closely interlinked clinical entities that frequently coexist [1–3] . CKD predisposes to AF through structural, inflammatory and... more

From vectors to victims: understanding the threat of West Nile virus infection

6 August 2025
Author(s): Raffaella Gallo, Rosanna C. De Rosa, Emanuele Durante-Mangoni

Growing numbers of West Nile virus infection cases are sparking fears among citizens and health care providers in Europe. In this Clinical Insight, we provide Internal Medicine physicians with a... more

Commentary

Navigating the pitfalls of pulmonary function testing in chronic lung allograft dysfunction and chronic pulmonary graft-versus-host disease

4 September 2025
Author(s): Libor Fila, Andrea Zajacova

Chronic lung allograft dysfunction (CLAD) and pulmonary chronic graft-versus-host disease (Pc-GVHD) represent the major late non-infectious pulmonary complications following lung and allogeneic... more

Addressing polymorbidity in chronic obstructive pulmonary disease: an opportunity to improve outcomes

1 September 2025
Author(s): David M. Mannino

Comorbid diseases are a common feature of chronic obstructive pulmonary disease (COPD), with most deaths among COPD patients from diseases other than chronic respiratory disease [1,2]. The importance... more

Molecular echoes of CPAP: Tracking hypoxia-sensitive non-coding RNAs in obstructive sleep apnea

27 August 2025
Author(s): María C García-Hidalgo, David de Gonzalo-Calvo

Obstructive sleep apnea (OSA) is a common and increasingly recognized disorder with complex systemic implications [1]. Beyond intermittent hypoxia and sleep fragmentation, OSA has been linked to... more

When the discovery of a biomarker stimulates basic interdisciplinary work on disease’s biology and pathophysiology

22 August 2025
Author(s): Vittorio Bellotti

The paper by Aimo et al. [1] reported in the current issue of the European Journal of Internal Medicine highlights a significant increase in the gamma-glutamyltransferase enzyme (GGT) in patients... more

Standard acute myocardial infarction without standard modifiable risk factors

16 August 2025
Author(s): Stefano Savonitto, Simona Giampaoli, Giuseppe De Luca

The identification of risk factors for cardiovascular diseases (CVD) using longitudinal cohort studies has been a major advance in medicine during the second half of the past century and, stimulating... more

Hijacked medical journals rank first via search engine optimization and threaten academic integrity

16 August 2025
Author(s): Mihály Hegedűs, Mehdi Dadkhah, Lóránt Dénes Dávid

The rise of questionable journals poses a significant threat to academic integrity, resulting in substantial waste of institutional and university resources. This commentary analysis focuses on six... more

Artificial intelligence in ECG interpretation: Promise and pitfalls of AI in modern medicine

16 August 2025
Author(s): Silvia Magnani, Maria Giovanni Bucci, Hussam Ali, Riccardo Cappato

The integration of artificial intelligence (AI) into cardiovascular diagnostics, particularly through electrocardiogram (ECG) analysis, represents one of the most promising frontiers in contemporary... more

Senolytic drugs to slow down aging: The Fountain of Youth, revisited

15 August 2025
Author(s): Raffaele Antonelli Incalzi, Claudio Pedone

Aging leads to progressive organ dysfunction, and many chronic degenerative diseases are characterized by accelerated aging of organs and apparatus. Thus, disentangling the effects of aging and age-... more

Uric acid and heart failure with mildly reduced ejection fraction (HFmrEF): one more step

7 August 2025
Author(s): Claudio Borghi, Giulia Fiorini

Uric acid (UA) is the terminal product of purine catabolism and arises from both endogenous nucleic acid turnover and exogenous intake—particularly from diets rich in animal protein and fructose [1... more

Hypochloremia no longer a “Carneades” in heart failure

5 August 2025
Author(s): Massimo Iacoviello, Pietro Scicchitano, Francesco Massari

“Carneades! Who was he?” is the opening phrase of Chapter VIII in *The Betrothed* (*I Promessi Sposi*), the most significant Italian novel of the 19th century, written by Alessandro Manzoni. Whit... more

In the line of fire: Sleep well as the first step of care

2 August 2025
Author(s): Maria Teresa La Rovere, Francesco Fanfulla

Sleep is a fundamental biological process that is essential for human life. A substantial body of research has indicated a correlation between inadequate sleep and adverse health consequences... more

Oral semaglutide in HFpEF: Real-world evidence and causal considerations

26 July 2025
Author(s): Victoria Catalán, Gema Frühbeck, Javier Gómez-Ambrosi

Heart failure with preserved ejection fraction (HFpEF) represents a significant and growing public health burden, with obesity and type 2 diabetes (T2D) emerging as major predisposing factors [1].... more

Redrawing the map for corticosteroids in severe community-acquired pneumonia

15 July 2025
Author(s): Grant Waterer, Jordi Rello

Current guidelines give a positive recommendation for the use of corticosteroids in severe community-acquired pneumonia (CAP) [1,2]. This is largely based on positive results from one of two recently... more

Modern data on blood pressure distribution in European children and adolescents

12 July 2025
Author(s): Paolo Verdecchia, Prerna Banati

Prevalence of hypertension in childhood is around 2–5 % [1,2] and it is progressively rising, particularly among adolescents from low-income countries [3]. Despite the solid evidence that... more

Corrigendum

Corrigendum to “Telemedicine in Internal Medicine: a statement by the European Federation of Internal Medicine” [European Journal of Internal Medicine 112C (2023) 138-139]

1 August 2025
Author(s): Filomena Pietrantonio, Sebastian Kuhn, Kati Kärberg, Tiffany Leung, Ismael Said-Criado, on behalf of the EFIM Telemedicine, Innovative Technologies and Digital Health Working Group

The authors regret that the author names were listed incorrectly in the manuscript, resulting in the author forenames and surnames becoming reversed. The correct presentation of the authorship is as... more

Editorial

“Limits to medicine” still needed after 50 years

7 July 2025
Author(s): Bjørn Hofmann

“The medical establishment has become a major threat to health” [1]. This opening statement and main point of Ivan Illich’s book Limits to medicine (Medical Nemesis) is more urgent than ever – but... more

Internal Medicine Flashcard

Ataxia, dysarthria and brainstem lesions in an elderly patient: a diagnostic challenge

25 August 2025
Author(s): Daniela Zermeño-Napolitano, Rodrigo Villaseñor-Echavarri, Latife Salame Khouri

A 75-year-old Hispanic man presented with a 3-year history of frequent falls conditioned by gait instability and generalized weakness. His symptoms progressed with worsening of gait imbalance,... more

A man with fever, retinal artery occlusion, atrioventricular block and bilateral renal masses

7 August 2025
Author(s): Raül Jordà-Sánchez, Rafael Salvador, Sergio Prieto-González

A 61-year-old man with a history of recurrent otitis and recent evaluation for submandibular salivary gland enlargement presented with sudden vision loss in the left eye. He also reported fever and... more

Progressive nodules in bilateral lower extremities

29 July 2025
Author(s): Wanting Yu, Hong Shen, Zehu Liu

A 58-year-old female patient presented with asymptomatic nodules that had been on her lower legs for 10 years. The nodules appeared spontaneously without any discernible cause and progressively... more

Smoking-induced “Scleroderma-like Pattern” and digital clubbing in a young adult

29 July 2025
Author(s): Angelo Nigro

A 24-year-old man with a 10-year history of heavy cigarette smoking (approximately 20 cigarettes per day) was evaluated for recurrent episodes of cold-induced hand erythema and bilateral digital... more

Recurrent bilateral infrapatellar subcutaneous nodules: what is the diagnosis?

28 July 2025
Author(s): Rodrigo Villaseñor-Echavarri, Yann Charli-Joseph, Gabriela Sánchez-Cárdenas

A 32-year-old Hispanic man presented with a one-month history of bilateral infrapatellar tender erythematous subcutaneous nodules (Fig. 1, a and b), accompanied by dysesthesias in the same area and... more

Fever and eye swelling in a teenager

28 July 2025
Author(s): Haruhiko Fukuchi, Kazuya Nagasaki

A 16-year-old male with a history of atopic dermatitis presented to his primary care clinic after 7 d of nasal discharge and obstruction, followed by fever and periorbital swelling, which resulted in... more

Dropped fingers

23 July 2025
Author(s): De-an Qin, Rui-feng Ji, Cong-hui Gao

A woman in her 60s presented with a one year history of a slowly-growing painful mass at the dorsal right wrist and sudden inability to actively lift her ring and little fingers without any trauma.... more

Constrictive pericarditis and tuberculosis: A second look

3 July 2025
Author(s): Abraham J. Beun, Maria Gabrovska, Rakan Nasreddine

A 42-year-old man presented with cough and nocturnal sweats since 3 weeks. He was being treated for pulmonary and lymph node tuberculosis (TB) since 5 months, and had improved both clinically and... more

Progressive skin thickening in a young adult

18 June 2025
Author(s): Thomas Didier, Sophie Leducq, Boris Laure

A 22-year-old man was referred to the dermatology service for the appearance of thickening of the skin, predominantly on the hands, feet and face, accentuation of the folds of the forehead and... more

Atypical and fatal presentation of acute liver failure

2 June 2025
Author(s): Ana Pérez González, Javier Martín López, Jesus Rivera-Esteban

A 44-year-old female presented to the emergency department with fever (38 °C) and general malaise three days after an elective hysterectomy for bleeding uterine fibroids. The procedure was... more

Invited Review Article

Lipoprotein (a): A new target for pharmacological research and an option for treatment

24 July 2025
Author(s): Angela Pirillo, Alberico L. Catapano

Lipoprotein(a) [Lp(a)] is increasingly recognised as a crucial and independent risk factor for atherosclerotic cardiovascular disease (ASCVD), calcific aortic valve stenosis (AVS), and possibly heart... more

Senolytic therapies for cardiovascular aging: tackling fibrosis and metabolic dysfunction

16 July 2025
Author(s): Sandra Atlante, Michela Gottardi Zamperla, Luca Cis, Antonella Farsetti, Carlo Gaetano

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, with its prevalence rising sharply with age [1,2]. Cellular senescence has emerged as a pivotal... more

Letter to the Editor

Association of social isolation with excess mortality risk and life expectancy in people with prediabetes and diabetes

27 August 2025
Author(s): Rui Chen, Ying Zhou, Xiaoxv Yin

Diabetes affects 589 million adults globally and significantly increases mortality risk by 1.6- to 2-fold, with an additional 1.1 billion people estimated to have early-stage glucose metabolism... more

Unaddressed limitations in triglyceride management among CHD patients: A call for methodological rigor

25 August 2025
Author(s): Kunal Mahajan, Jai Bharat Sharma, Surender Himral, Shivali Sandal

We have carefully reviewed the article by Ilay Shani and Avishay Elis, “The Approach to Triglyceride Levels in Patients with Coronary Heart Disease,” and commend the authors for their comprehensive... more

Potassium instability and prognosis in acute heart failure: Practice-oriented reflections

25 August 2025
Author(s): Shaoxiang Huang, Xueyu Wang, Peili Zhang

We read with interest the article, “Association between serum potassium variability during admission for decompensated heart failure and outcomes,” published in the European Journal of Internal... more

Critical considerations on sTREM2 as a biomarker for early MASH in women with severe obesity

21 August 2025
Author(s): Jingyi Li, Xizhuang Gao

We commend Mahmoudian et al. for their insightful study investigating soluble TREM2 (sTREM2) as a noninvasive biomarker for early metabolic dysfunction-associated steatohepatitis (MASH) in women with... more

Phosphatidylethanol and venous thromboembolism risk – clinical implications and future directions

19 August 2025
Author(s): Daniel Matovu

I read with great interest the prospective study by Johansson et al. [1] published in the European Journal of Internal Medicine, which investigates the association between phosphatidylethanol (PEth)... more

Optimizing potassium control in hospitalized heart failure patients: Unanswered questions and future perspectives

18 August 2025
Author(s): Siyu Feng, Quan Zhou, Huaqiang Xu

We read with great interest the recent article by Suzuki et al., recently published in the European Journal of Internal Medicine [1]. The authors address an important and often overlooked aspect of... more

Not just the level – the importance of potassium stability in patients with heart failure

9 August 2025
Author(s): Tobias Schupp, Ibrahim Akin, Michael Behnes

We read with great interest the manuscript by Suzuki et al. investigating the prognostic impact of changes of serum potassium levels during index hospitalization in a large cohort of 1280 patients... more

Unmeasured burdens in nonagenarian ICU survivors: A cohort-based perspective

8 August 2025
Author(s): JiaHao Shi

I read with interest the recent study by Weller and colleagues on excess mortality in ICU patients aged 90 years and older. Their use of relative survival provides instructive information about... more

Cardiac outcomes in hypertrophic cardiomyopathy treated with beta-blockers or verapamil

5 August 2025
Author(s): Laurent Fauchier, Lisa Lochon, Thibault Lenormand, Alexandre Bodin, Arnaud Bisson

In hypertrophic cardiomyopathy (HCM), beta-blockers (BBs) and non-dihydropyridine calcium channel blockers (particularly verapamil) are both used to manage symptoms such as dyspnea, chest pain, and... more

Effect of resmetirom on lipid profile and adiponectin levels

5 August 2025
Author(s): Luis E. Simental-Mendía, Mario Simental-Mendía, Laura Jazel Barragán-Zúñiga, Litzy Navarro-Tinoco

Resmetirom, a novel liver-targeted selective thyroid hormone receptor-beta (THR-β) agonist, has shown positive effects for the treatment of dyslipidemia and other metabolic disorders, including non-... more

Classification of coronary syndromes: Need for refinement?

5 August 2025
Author(s): Andrea Rubboli

In addition to providing a common language, and thus facilitating communication among professionals, medical classifications aim to incorporate clinical and pathophysiological elements that help... more

DOACs vs. VKAs for renal protection: An established superiority gives rise to a new clinical paradox

18 July 2025
Author(s): Ahmed B. Shamsulddin

I commend Adamou and colleagues for their important meta-analysis, which reinforces the established superiority of direct oral anticoagulants (DOACs) over vitamin K antagonists (VKAs) for preserving... more

In ageing research the slope matters

16 July 2025
Author(s): Jan Frederic Weller, Liesbeth C. de Wreede, Kevin Roedl, Frederik Peters, Maximilian Christopeit

We appreciate the thoughtful commentaries by Ye & Huang and Incalzi & Pedone regarding our study on relative survival in intensive care unit (ICU) patients aged 90 years and over [1–3].

Drug-induced hyponatremia in clinical care. Authors' reply

10 July 2025
Author(s): B. Mannheimer, J.D. Lindh, H. Falhammar, J. Skov

We extend our sincere gratitude to Ben Salem et al. for their letter commenting on the review “Drug-induced hyponatremia in clinical care” recently published [1,2].

Mapping the clinical trial landscape of gut microbiota modulation in neurodegenerative diseases

3 July 2025
Author(s): Hui Chen

Neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS), are increasingly recognized as major contributors to the global burden of disease... more

Association of serum potassium time in target range with all-cause and cardiovascular mortality in HFrEF patients

3 July 2025
Author(s): Wenlong Xu, Yifei Ruan, Zhiwen Xiao, Xiaobo Huang, Yanmei Chen

Dyskalemia is relatively common in heart failure with reduced ejection fraction (HFrEF). Both hypokalemia and hyperkalemia exhibit U-shaped associations with adverse outcomes in HFrEF, including... more

Extended anticoagulation therapy on clinical outcomes in patients with gastrointestinal cancer and isolated distal deep vein thrombosis: Insights from the ONCO DVT Study

30 June 2025
Author(s): Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Koh Ono, Takeshi Kimura, ONCO DVT Study Investigators

The current guidelines have recommended prolonged anticoagulation therapy with direct oral anticoagulants (DOACs) as a potential treatment option for patients with cancer-associated venous... more

Cancer treatment-associated hypomagnesemia: Analysis from a large pharmacovigilance database

30 June 2025
Author(s): Nattawat Klomjit, Richard Evans, Meghan E. Sise, Kenar D. Jhaveri, Shruti Gupta, on behalf of the Hypomagnesemia in Cancer Treatment Working Group

Hypomagnesemia is common among patients with cancer, and can lead to increased morbidity and mortality as well as discontinuation of potentially life-saving treatments. Hypomagnesemia may occur due... more

Are ACE2 rs2285666 and TMPRSS2 rs12329760 polymorphisms a risk factor for the development of Post-COVID-19 condition?

28 June 2025
Author(s): César Fernández-de-las-Peñas, Lars Arendt-Nielsen, Antonio Gil-Crujera, Stella M. Gómez-Sánchez, Gema Díaz-Gil

Evidence on viral mechanisms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent causing the coronavirus disease, 2019 (COVID-19), suggests the involvement of several receptors... more

Efficacy and safety of beta-blockers in patients with comorbid chronic obstructive pulmonary disease and cardiovascular disease

20 June 2025
Author(s): Tejuss Kakarla, Yash Vardhan Trivedi, Parth Munjal, Avi Kumar, Rohit Jain

To the editor: Chronic Obstructive Pulmonary Disease (COPD) and cardiovascular disease (CVD) often co-occur, presenting complex management challenges due to concerns over the effects of beta-blockers... more

Addressing unmet needs in the use of SGLT2 inhibitors in critical and acute care setting

16 June 2025
Author(s): Damiano D’Ardes, Fabrizio Ricci, Paola Simeone, Andrea Boccatonda, Francesca Santilli

Despite mounting evidence of benefit in acute heart failure (AHF), acute myocardial infarction (AMI), arrhythmias, and even intensive care settings, there remains a significant lack of clear guidance... more

Role of 12-lead electrocardiogram for identifying very low mortality risk patients with non-hypotensive acute pulmonary embolism

7 June 2025
Author(s): Crhistian-Mario Oblitas, Francisco Galeano-Valle, Luis-Antonio Alvarez-Sala Walther, Pablo Demelo-Rodríguez

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality and a significant global health issue [1]. The simplified Pulmonary Embolism Severity Index (sPESI) is a practical tool... more

Real-world glucose-lowering strategies for managing glucocorticoid-induced diabetes in non-intensive hospital settings

5 June 2025
Author(s): Michela Vergani, Matteo Conti, Alessia Lari, Federico Bertuzzi, Basilio Pintaudi

A prolonged administration of glucocorticoids (GCs) can lead to side effects such as glucocorticoid-induced diabetes (GC-DM), a form of secondary diabetes, namely drug- or chemical-induced diabetes [... more

Gastroenteritis caused by Shiga-toxigenic Escherichia coli. Are antibiotics always prohibited in this disease?

4 June 2025
Author(s): Juan Gabriel Sánchez-Cano, Ana Belén Mecina-Gutiérrez, Carolina Campelo-Gutiérrez, María Velasco-Arribas, Leonor Moreno-Núñez

Dear Editor-in-Chief and editorial team,

Validation of different acute kidney injury scores in patients undergoing transcatheter aortic valve implantation

29 May 2025
Author(s): Andrea Milzi, Antonio Landi, Daniel Sürder, Giovanni Pedrazzini, Marco Valgimigli

Contrast-associated acute kidney injury (CA-AKI) remains one of the most relevant procedural complications in patients undergoing transcatheter aortic valve implantation (TAVI). Beyond contrast dye... more

Drug-induced hyponatremia in clinical care

28 May 2025
Author(s): Chaker Ben Salem, Dhouha Sahnoun

In their excellent literature review, Mannheimer B et al. do not include several drugs that may induce hyponatremia [1]. Various dopaminergic agents are associated with hyponatremia.

Unmasking atrial cardiomyopathy in middle-aged patients with AF: A call for early detection

27 May 2025
Author(s): A. Borizanova, E. Kinova, A. Goudev

Atrial cardiomyopathy (AtCM) has emerged as a critical clinical entity in recent years, encompassing structural, architectural, electrical, and functional abnormalities in the atria [1]. Atrial... more

Nonarteritic anterior ischemic optic neuropathy and glucagon-like peptide-1 receptor agonists: Evaluating a potential association

21 May 2025
Author(s): Laşin Özbek, Mustafa Güldan, Derya G. Fidan, Sama Mahmoud Abdel-Rahman, Mehmet Kanbay

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used for type 2 diabetes mellitus (T2DM) and obesity due to their efficacy in glycemic control, weight reduction, and... more

The role of the hospitalist in Europe: results by EFIM multimorbidity working group survey

21 May 2025
Author(s): Ombretta Para, Flora Kisuule, Arántzazu Álvarez-de Arcaya, Antonio Gonzalez Fernandez, Maximo Bernabeu-Wittel

The increasing prevalence of chronic diseases has led to a population with a higher level of care complexity. Multimorbidity (MM) has emerged as the most prevalent patient profile in both outpatient... more

Abrupt fluoroquinolone-associated suicides: a SONAR report from North America, Europe, Australia, and Asia

13 May 2025
Author(s): Charles L. Bennett, Mia Lynch, Gretchen LeFever Watson, Linda Martin, June M. McKoy, for the Southern Network and Advserse Reactions

One billion doses of fluoroquinolone (FQ) antibiotics have been administered since 1987. In 1998, the German Pharmaceutical Regulatory Agency received “a few” suicide reports that occurred shortly... more

Hyponatremia and mortality: Marker of disease or modifiable risk? Rethinking causality in large-scale observational research. Authors’ reply

13 May 2025
Author(s): Buster Mannheimer, Jonatan D. Lindh, Issa Issa, Henrik Falhammar, Jakob Skov

We would like to thank Xia et al. for their thorough evaluation of our recent work based on the Stockholm Sodium Cohort (SSC) [1,2], in which they raise several concerns, some of which are inherent... more

Genotype-phenotype correlations and resistance to colchicine in a familial Mediterranean fever cohort in southwestern Spain

13 May 2025
Author(s): Carlos Hernández Quiles, Ana Casado Díaz, Aurora González Estrada, Marco Antonio Montes Cano, José Salvador García Morillo

Familial Mediterranean Fever (FMF) is the most frequent autoinflammatory disease, characterized by recurrent episodes of fever, abdominal pain, arthritis, and rash. It primarily affects people in the... more

Disabling hearing loss in ischemic stroke: Prevalence, predictors, and prognostic implications

30 April 2025
Author(s): Angeline Yi Ling Teo, Hazel Kai Hui Yeo, Amy May Lin Quek, Jenny Hooi Yin Loo, Raymond Chee Seong Seet, Hearing in Stroke Study Group

Growing evidence suggests that hearing loss may be an overlooked risk factor and consequence of ischemic stroke [1]. Several large-scale cohort analyses indicate that individuals with hearing loss... more

Hyponatremia and mortality: Marker of disease or modifiable risk? Rethinking causality in large-scale observational research

25 April 2025
Author(s): Xin Xia, Tao Zhang, Kai Zhao, Kun Huang

We read with great interest the article by Mannheimer et al. investigating mortality and causes of death in patients hospitalized with hyponatremia using a large propensity-matched cohort from the... more

Prognostic impact of bone scintigraphy in elderly patients with hypertrophic cardiomyopathy

21 April 2025
Author(s): Younes Kamal, Lisa Lochon, Anne Bernard, Arnaud Bisson, Laurent Fauchier

Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition that may result from sarcomeric mutations or infiltrative disorders such as transthyretin amyloid cardiomyopathy (ATTR-CM) [1].... more

Prevalence, awareness, and control of cardiovascular risk factors among specialists in cardiovascular field: A survey

19 April 2025
Author(s): Claudia Agabiti Rosei, Rita Del Pinto, Maria Lorenza Muiesan, Claudio Ferri, Guido Grassi, PROTECTO study group

Dear Editor,

Short term variability of peripheral blood eosinophil count in individuals with stable COPD

16 April 2025
Author(s): Claudio Candia, Claudia Merola, Salvatore Fuschillo, Pasquale Ambrosino, Nicolino Ambrosino, Mauro Maniscalco

Chronic obstructive pulmonary disease (COPD) is typically considered a neutrophil-driven inflammatory disease [1], but some individuals, particularly those with frequent exacerbations, show... more

Trends in cardiovascular disease-related mortality among adults with sleep apnea in the United States from 1999-2020

15 April 2025
Author(s): Usama Qamar, Siddharth Agarwal, Maaz Asif, Waleed Qamar, Zain Ul Abideen Asad

Cardiovascular disease-related mortality in adults with comorbid sleep apnea in the United States from 1999 to 2020.

Cardiovascular safety and efficacy of intensive blood pressure control: how low should we go?

14 April 2025
Author(s): Paschalis Karakasis, Dimitrios Patoulias, Antonios P Antoniadis, Nikolaos Fragakis, Ricardo Gómez-Huelgas

Dear Editor,

Excess risk or misestimated baseline? Reconsidering relative survival in the oldest ICU patients

11 April 2025
Author(s): Juan Ye, Kun Huang

We commend Weller et al. for their important and timely contribution, which provides a rigorous and impressively sized analysis of 1076 ICU patients aged 90 years and older, using relative survival... more

Original Article

The Implementation of the Acute Basic Palliation Concept in Newly introduced Hospital Departments: An Explorative Observational Study of Non-Specialized Palliative Patients Discharged to Die at Home in Denmark

29 August 2025
Author(s): Dorte Melgaard, Matilde Alida Arendt Eriksen, Jakob Fogh Jørgensen, Harman Yonis, Rikke Bramming, Laurits Dalsgaard, Camilla Ly, Bensu Izgi, Annika Kamp, Natasja Uldall, Luise Lilleøre, Maiken Faklam Dalsgaard Knudsen, Marte Brenna Steinbakken, Christian Bille, Kalle Lindbjerg, Julie Bjerke, Abeda Samadi, Anne Lund Krarup

Palliative Care (PC) is a key component of patient-centred healthcare, focusing on relieving the symptoms, pain, dignity and stress of patients with serious, life-limiting conditions. A widely... more

Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry

25 August 2025
Author(s): Paolo Prandoni, Meg Fluharty, Sebastian Schellong, Henri Bounameaux, Sylvia Haas, Lorenzo G Mantovani, Sherif Sholkamy, Katsuhiro Kondo, Harry Gibbs, Zhi-Cheng Jing, Chern-En Chiang, Peter Verhamme, Alexander GG Turpie, Jeffrey I. Weitz, Walter Ageno, Shinya Goto, Pantep Angchaisuksiri, Karen Pieper, Ajay K Kakkar, GARFIELD-VTE Investigators

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a major cause of morbidity and mortality [1] VTE is linked to several risk factors, including age,... more

Impact of a Checklist-Based Strategy for Cardiac Amyloidosis Screening on Diagnosis Rates in Heart Failure Patients (CHECKAMIC Study)

21 August 2025
Author(s): Alberto Pérez-Nieva, Pau Llàcer, Prado Salamanca-Bautista, Miquel Camafort, Marina García-Melero, Rocio Ruiz-Hueso, Ana Suárez, Carlos Pérez, Irene Bravo-Candela, Raul Ruiz, Anna Aldea, Genoveva López, Cristina Fernández, María del Prado Orduña, Martín Fabregate, Oscar Aramburu-Bodas, Luis Manzano

Amyloidosis is a storage disease caused by the extracellular deposition of fibers derived from structural alterations of unstable proteins, which after folding and aggregation are finally deposited... more

An exploratory model for short-term risk stratification in intermediate-high-risk pulmonary embolism running head: The STAMP score

20 August 2025
Author(s): Marco Zuin, Claudio Bilato, Iolanda Enea, Amedeo Bongarzoni, Franco Casazza, Loris Roncon, Cecilia Becattini

Patients with acute pulmonary embolism (PE) characterized by hemodynamic stability, evidence of right ventricular (RV) dysfunction (RVD), positive cardiac biomarkers and high simplified pulmonary... more

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients

19 August 2025
Author(s): Elisabetta Goni, Jens Vikse, Marco Lanzillotta, Bjørg-Tilde Svanes Fevang, Øyvind Midtvedt, Jasmin Mahajne, Veronica Batani, Giovanni Benanti, Georg Beyer, Lorenzo Dagna, Øyvind Molberg, Katrine Brække Norheim, Ulf Schönermarck, Ivonne Regel, Julia Mayerle, Anna-Maria Hoffmann-Vold, Emanuel Della-Torre

IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition with marked clinical heterogeneity [1]. Common manifestations include autoimmune pancreatitis and cholangitis, orbital... more

Non cardiovascular comorbidities in Heart Failure. An updated position paper from the Heart Failure Working Group of the Italian Society of Cardiology (SIC)

19 August 2025
Author(s): Michele Correale, Andrea Salzano, Lucia Tricarico, Antonio Cittadini, Giulia Crisci, Giuseppe Dattilo, Riccardo Maria Inciardi, Emiliano Fiori, Stefania Paolillo, Gaetano Ruocco, Angela Sciacqua, Paolo Severino, Valentina Mercurio, Piergiuseppe Agostoni, Francesco Barillà, Frank Lloyd Dini, Pasquale Perrone Filardi, Savina Nodari, Alberto Palazzuoli, Italian Society of Cardiology (ISC) Working Group on Heart Failure

Heart Failure (HF) affects more than 64 million people worldwide[1]. While the incidence of HF has stabilized, its prevalence is increasing due to the ageing of the population, improvements in the... more

Long term fluid volume fluctuations and mortality in kidney failure patients on long term hemodialysis treatment

16 August 2025
Author(s): Carmine Zoccali, Giovanni Tripepi, Paola Carioni, Francesca Mallamaci, Matteo Savoia, Len S Usvyat, Franklin W. Maddux, Stefano Stuard

The prognosis of patients kidney failure (KF) patients on long term hemodialysis treatment is one of the most severe among chronic diseases, and only modest progress has been made over the last... more

A person-centred clinical approach to the multimorbid patient with COPD

12 August 2025
Author(s): Bartolome R. Celli, Leonardo M. Fabbri, Abebaw M. Yohannes, Nathaniel M. Hawkins, Gerard J. Criner, Jessica Bon, Marc Humbert, Christine R. Jenkins, Leonardo Pantoni, Alberto Papi, Jennifer K. Quint, Sanjay Sethi, Daiana Stolz, Alvar Agusti, Don D. Sin

Multimorbidity, the coexistence of multiple non-communicable diseases in an individual, is a growing concern, especially in an aging population [1]. Patients with chronic obstructive pulmonary... more

Bleeding risk on rivaroxaban versus apixaban in older patients with venous thromboembolism: a nationwide observational register-based study

11 August 2025
Author(s): Maria Roupe, Annika Rosengren, Aldina Pivodic, Rebecka Bertilsson, Jacob Philipson, Kristina Svennerholm, Mazdak Tavoly, Katarina Glise Sandblad

During primary treatment, apixaban was associated with a lower risk of major bleeding than rivaroxaban without a corresponding increase in recurrent PE risk. During secondary treatment, no difference... more

Venous thromboembolism associated with infections: a systematic review and meta-analysis

7 August 2025
Author(s): Panagiotis Stathopoulos, Stelios-Elion Bousi, Marinos Zachiotis, Athanasios Lampropoulos, Stylianos A. Kakoullis, Charalambos Michaeloudes, Matthew E. Falagas

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), has long been a significant cause of severe disease and death. At the same time, its etiology is... more

A prospective study of the association between phosphatidylethanol concentration and risk of first-ever venous thromboembolism

2 August 2025
Author(s): Magdalena Johansson, Anders Själander, Marcus M Lind, Lars Johansson

Venous thromboembolism (VTE) is a common term for deep vein thrombosis (DVT) and pulmonary embolism. The overall incidence rate of VTE in adults is 1–2 per 1000 person-years and has increased... more

Transthyretin serum levels and clinical outcomes in patients with transthyretin amyloid cardiomyopathy

29 July 2025
Author(s): Annamaria Minervini, Gonzalo Barge-Caballero, Andrea López-López, Manuel López-Pérez, Eva González-Babarro, Inés Gómez-Otero, Raquel Bilbao-Quesada, Mario Gutiérrez-Feijoo, Alfonso Varela-Román, Alberto Bouzas-Mosquera, María G. Crespo-Leiro, Eduardo Barge-Caballero

Over the last decade, significant advances have been made regarding the knowledge of the biological bases, diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), which currently... more

Cluster analysis for clinical, radiological, and histopathological profiling in chronic pulmonary graft-versus-host disease

28 July 2025
Author(s): Sara Piciucchi, Marco Chilosi, Giuseppe Alfano, Simone Petrarulo, Roland Barbante, Emanuela Giampalma, Claudia Ravaglia, Pier Luigi Zinzani, Venerino Poletti

Chronic pulmonary graft-versus-host disease (Pc-GVHD) is a non-infectious complication of allogeneic hematopoietic stem cell transplantation (HSCT), typically presenting >100 days post-... more

sTREM2 evaluation in women with metabolic dysfunction-associated steatotic liver disease: Advancing diagnostic approaches for early MASH

27 July 2025
Author(s): Razieh Mahmoudian, Helena Clavero-Mestres, Elena Cristina Rusu, Vicente Arredondo-Prats, Carmen Aguilar, Javier U Chicote, Salomé Martinez, David Riesco, Èlia Bartra, Anna Trinidad Borras, Fàtima Sabench, Teresa Auguet

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD) [1], is an emerging public health concern affecting approximately 32.4... more

Whether an optimal strategy exists for VTE prevention in critically ill patients: Insights from guidelines and randomized controlled trials

25 July 2025
Author(s): Di Wei, Sinan Ma, Weijia Huang, Ting Yang, Keyu Chen, Baoni Sun, Xinye Li, Li Zhang, Yan Wang

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant concern in critically ill patients. Effective prevention is vital due to its high... more

Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiency

24 July 2025
Author(s): Naomi N. Kappe, Malin Fromme, Jan Stolk, Ilaria Ferrarotti, Pavel Strnad, Bart van Hoek

Alpha-1 antitrypsin deficiency (AATD) is a hereditary condition caused by mutations in the SERPINA1 gene, encoding alpha-1 antitrypsin (AAT), an important antiprotease in the lungs that is primarily... more

Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic review

16 July 2025
Author(s): Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi

The definition of blood pressure (BP) targets in treated hypertensive patients remains controversial. Some Guidelines recommend an ideal systolic BP target of <140 mmHg, with different targets... more

Association between serum potassium variability during hospitalization and clinical outcomes in patients with heart failure

16 July 2025
Author(s): Yoshinori Suzuki, Tomofumi Misaka, Yu Sato, Satoshi Okochi, Ryo Ogawara, Shohei Ichimura, Tetsuro Yokokawa, Akihiko Sato, Takeshi Shimizu, Takamasa Sato, Takashi Kaneshiro, Masayoshi Oikawa, Atsushi Kobayashi, Akiomi Yoshihisa, Yasuchika Takeishi

Serum potassium levels are tightly regulated within a narrow physiological range, typically 3.5–5.0 mEq/L [1]. Potassium homeostasis involves maintaining a concentration gradient between... more

Clinical characteristics and outcomes of patients with acute myocardial Infarction without standard modifiable risk factors (SMuRFs)

12 July 2025
Author(s): Dimitrios V. Moysidis, Vasileios Anastasiou, Stylianos Daios, Andreas S. Papazoglou, Efstratios Karagiannidis, Barbara Fyntanidou, Vasileios Kamperidis, Matthaios Didagelos, Sonia Konstantinidou, Christos Savopoulos, Kali Makedou, Panagiotis Kyriakidis, George Giannakoulas, Antonios Ziakas, Georgios Giannopoulos, Vassilios Vassilikos

The etiology as well as the prevalence of acute myocardial infarction (AMI) in patients without history of standard modifiable risk factors (SMuRFs) remains unclear, especially in European... more

Venous thromboembolism associated with weak transient risk factors in young women: risk of late recurrence. An international cohort study

12 July 2025
Author(s): Victoria Bitsadze, Mariya Gennadevna Nikolaeva, Eve Mousty, Jamilya Khizroeva, Jeremy Laurent, Sylvie Ripart, Lorris Le Collen, Salim Allal, Mathieu Fortier, Sylvie Bouvier, Mathias Chea, Antonia Perez-Martin, Alexander Makatsariya, Jean-Christophe Gris

After a first episode of venous thromboembolism (VTE) treated according to the guidelines, the risk of thrombotic recurrence must be assessed in order to guide medical treatment. The clinical risk... more

Deterioration of renal function is delayed in patients with atrial fibrillation treated with direct oral anticoagulants compared to vitamin K antagonists: systematic review and meta-analysis

9 July 2025
Author(s): Anastasia Adamou, Ioannis Kyriakoulis, Polyxeni Botou, Ioannis Belios, Iliana Stamatiou, David Dimitris Chlorogiannis, Theodoros Mavridis, George Ntaios

The use of anticoagulants has been linked to anticoagulant-related nephropathy (ARN), a condition initially reported in patients treated with warfarin [1]. However, cases have also been documented in... more

Prognostic impact of uric acid levels in heart failure with mildly reduced ejection fraction: Insights from a large retrospective registry

8 July 2025
Author(s): Alexander Schmitt, Michael Behnes, Thomas Bertsch, Marielen Reinhardt, Michelle Goertz, Noah Abel, Felix Lau, Kathrin Weidner, Jonas Dudda, Henning Johann Steffen, Mohammad Abumayyaleh, Daniel Duerschmied, Ibrahim Akin, Tobias Schupp

Elevated uric acid (UA) levels represent an established risk factor for cardiovascular morbidity and mortality [1–3]. Numerous investigations have demonstrated an association between increased UA and... more

Point of care ultrasound (POCUS) applications in the ambulatory internal medicine setting: A scoping review

7 July 2025
Author(s): Michael Pratte, Mathilde Gaudreau-Simard, Sydney Ruller, Kordan Harvey, Valentina Ly, Jessica Evans

Point of care ultrasound (POCUS) is an increasingly recognized tool in internal medicine, with evidence supporting its use largely derived in the inpatient setting. We endeavored to provide an... more

Modulation of hypoxia-sensitive non-coding RNAs following continuous positive airway pressure therapy in obstructive sleep apnea in peripheral blood

2 July 2025
Author(s): Francesco Fanfulla, Veronica Barbi, Tiziana Bachetti, Roberto Maestri, Elena Robbi, Alessia Mongelli, Teresa Lucia Aloi, Caterina Pronzato, Michela Gottardi Zamperla, Simona Greco, Fabio Martelli, Maria Teresa La Rovere, Carlo Gaetano

Obstructive sleep apnea (OSA) is a chronic clinical condition characterized by recurrent apnea or hypopnea during sleep, leading to intermittent hypoxemia, arousal, and sleep fragmentation. OSA... more

Sex-related differences in the management and outcome of intubated adults with community-acquired pneumonia in Europe: A multicentre study

1 July 2025
Author(s): Nicolas Garin, Despoina Koulenti, Virginie Prendki, Jordi Rello

Sex and gender are increasingly recognized determinants in the epidemiology, clinical presentation, management, response to treatment, and prognosis of chronic and acute diseases [1]. Sex refers to... more

Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study

28 June 2025
Author(s): Irene Mattioli, Michela Gasparotto, Alberto Bergamini, Alessandra Bortoluzzi, Francesco Ciccia, Fabrizio Conti, Maria Antonietta D'agostino, Micaela Fredi, Roberto Giacomelli, Florenzo Iannone, Ilaria Mormile, Matteo Piga, Luca Quartuccio, Gian Domenico Sebastiani, Chiara Tani, Angelo Vacca, Margherita Zen, Alessandra Bettiol, Giacomo Emmi, ESCULAPIO consortium

Systemic Lupus Erythematosus (SLE) is a multifaceted systemic autoimmune disorder distinguished by a diverse array of clinical manifestations that can potentially impact any organ or system in the... more

Neurologic and psychiatric disorders following correction of profound hyponatremia - A cohort study

25 June 2025
Author(s): Henrik Falhammar, Mikael Andersson Franko, Jonatan D. Lindh, Jakob Skov, Buster Mannheimer

Hyponatremia, defined as a serum sodium concentration <135 mmol/L, is the most common electrolyte imbalance, seen in 15–20 % of all acute hospital admissions [1]. Women, elderly, and individuals... more

Survival effect of early high-flow nasal oxygen after the extubation of patients in the intensive care unit

24 June 2025
Author(s): Atsushi Ishihara, Hideshi Okada, Teruki Mori, Takashi Yoshizane, Kentaro Morishita, Takuji Yamamoto, Izumi Toyoda, Toshiyuki Noda

Spontaneous awakening trial (SAT) and spontaneous breathing trial (SBT) protocols for mechanically ventilated patients in the intensive care unit (ICU) have been shown to reduce the duration of... more

Prognostic value of N-terminal prohormone B-type natriuretic peptide modified by renal function in patients with acute heart failure

21 June 2025
Author(s): Rui Zhu, Yaoyao Wang, Lili Liu, Xuejiao Liu, Zhanyuan Chen, Yu Wei, Weifeng Lin, Lihua Zhang, Guangda He, Jianfang Cai

Heart failure (HF), as the final phase of various cardiovascular disorders, imposes a formidable global healthcare challenge due to its diverse morbidity and high rate of mortality [1]. HF and kidney... more

Determinants of time to first palliative care consultation in hospitalized patients with advanced or terminal illness – A retrospective analysis

19 June 2025
Author(s): Christopher Paschen, Franziska Ecker, Patrick Haider, Claudia Wenzel, Eva Katharina Masel

The Yentl Syndrome, a term coined by Dr. Bernadine Healy in 1991, refers to the phenomenon that women are less likely to receive accurate diagnosis and treatment because their symptoms do not align... more

Blood pressure values in healthy normal weight children and adolescents in eight European countries: auscultatory and oscillometric measurements

19 June 2025
Author(s): Lurbe E, Regueiro-Ons C, Mancia G, Düzova A, Erdine S, Herceg-Cavrak V, Kulaga Z, Litwin M, Pall D, Petricevic N, Seeman T, Simão C, Stabouli S, Redon J, González López-Valcarcel B

The importance of high blood pressure (BP) as a modifiable risk factor for early disability and death is well established [1]. Although the majority of adverse outcomes occur in adulthood, high BP is... more

Long-term quality of life after sleeve gastrectomy vs Roux-en-Y Gastric Bypass in patients with severe obesity: Results from the SleeveBypass multicentre randomised controlled trial

19 June 2025
Author(s): J.W.H. ‘t Hart, B.J. Noordman, E. Birnie, J.F. Smulders, S. Nienhuijs, M. Dunkelgrün, J.F. Zengerink, I.A.M. Friskes, G.H.H. Mannaerts, C. Verhoef, J.A. Apers, L.U. Biter

Obesity is a chronic condition and a worldwide problem that poses health risks, reduces quality of life (QoL), contributes to psychosocial issues and increases public healthcare costs [1]. While,... more

Efficacy and safety of once-daily oral semaglutide in patients with heart failure with preserved ejection fraction, type 2 diabetes and obesity: a real-world study

14 June 2025
Author(s): Alicia Trenas, Miguel A. Pérez-Velasco, Maria-Rosa Bernal-López, María-Dolores López-Carmona, Juan J. Gómez-Doblas, María-Dolores Martínez-Esteban, Oumayma Bouarich, Natalia García-Casares, Diego Fernández-García, María-Dolores García de Lucas, Ricardo Gómez-Huelgas, Luis M. Pérez-Belmonte

Heart failure with preserved ejection fraction (HFpEF) is a complex and multifactorial heart disease. It has become the most common type of heart failure (HF), which can be explained in part by its... more

Identification of risk factors for permanent visual loss in patients with giant cell arteritis

14 June 2025
Author(s): Roser Solans-Laqué, Begoña de Escalante-Yanguela, Eva Fonseca, Guadalupe Fraile, Ferran Martínez-Valle, Luis Caminal, Manuel Monteagudo, Mercedes Pérez-Conesa, Borja Gracia-Tello, Monica Abdilla, Sergio Prieto-González, Aleida Martínez-Zapico, Borja de Miguel-Campo, Jaume Mestre-Torres, REVAS-Registry, from the Systemic Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI)

Giant cell arteritis (GCA) is the most common systemic vasculitis affecting older people in Western countries, being more prevalent in females [1–4]. Vascular inflammation predominantly affects the... more

Current epidemiology, risk factors and influence on prognosis of multidrug resistance in Klebsiella spp. bloodstream infection. Insights from a prospective cohort

12 June 2025
Author(s): Jorge Calderón-Parra, María Teresa Carretero-Henriquez, Gabriela Escudero, Elena Suances-Martin, Marta Murga de la Fuente, Patricia González-Merino, Ane Andrés-Eisenhofer, Ana Visedo-Colino, Ana Rodríguez, Ana Rojo-Reyes, Itziar Diego-Yagüe, Andrea Gutiérrez-Villanueva, Isabel Sánchez-Romero, Antonio Ramos-Martinez

Klebsiella spp. are the third most common cause of bloodstream infections, only after Escherichia coli and Staphylococcus aureus, both in the community and nosocomial infections [1]. Usually arising... more

Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation

12 June 2025
Author(s): TE Hunt, GM Traaen, L Aakerøy, B Øverland, C Bendz, AE Michelsen, S Steinshamn, KH Haugaa, OG Anfinsen, P Aukrust, K Broch, H Akre, JP Loennechen, L Gullestad, T Ueland

Sleep apnea and AF are both associated with adverse cardiovascular outcomes [1,2]. Obstructive sleep apnea (OSA) is more prevalent in patients with atrial fibrillation (AF) than in patients with... more

Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factors

11 June 2025
Author(s): Pau Llàcer, Marta Cobo Marcos, François Croset, Isabel Zegrí-Reiriz, Rafael de la Espriella, Jara Gayán Ordás, Aleix Fort, Jorge Rubio-Gracia, Zorba Blázquez-Bermejo, Ana Méndez, Adriana Rodríguez, Pedro Caravaca-Pérez, Josep Comín-Colet, Jose Luis Morales-Rull, Luis Manzano, Julio Núñez

Traditionally, sodium and potassium disorders have been considered the most relevant ionic disturbances in heart failure (HF)., [1] However, in recent years, hypochloremia has emerged as a critical... more

Gamma-glutamyltransferase independently predicts mortality and heart failure hospitalization in cardiac transthyretin amyloidosis

11 June 2025
Author(s): Alberto Aimo, Vincenzo Castiglione, Daniela Tomasoni, Giovanni Battista Bonfioli, Giorgia Panichella, Giulio Sinigiani, Alessandro Lupi, Aldostefano Porcari, Navneet Kaur, Marco Merlo, Alberto Cipriani, Gianfranco Sinagra, Maria Franzini, Giuseppe Vergaro, Michele Emdin

Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded transthyretin (TTR) fibrils within the myocardium, leading to progressive... more

The approach to triglyceride levels in patients with coronary heart disease

11 June 2025
Author(s): Ilay Shani, Avishay Elis

Hypercholesterolemia is one of the major modifiable cardiovascular risk factors, while current guidelines mark the low-density lipoprotein cholesterol (LDL-C) levels as the primary target of... more

Long-term secondary prevention with colchicine in patients with CAD: an updated systematic review and meta-analysis

6 June 2025
Author(s): Patrizia Boracchi, Giuseppe Marano, Ester Luconi, Claudio Cimminiello

Randomized clinical trials (RCTs) for the prevention of vascular events in patients with coronary artery disease (CAD) over the past decade have clearly demonstrated that colchicine is able to reduce... more

Latent class analysis identifies novel coeliac disease subgroups with distinctive clinical features: a multicentric study

30 May 2025
Author(s): Marco Vincenzo Lenti, Daniele Pala, Nicola Aronico, Arianna Dagliati, Paola Ilaria Bianchi, Giovanni Santacroce, Silvana Quaglini, Giordano Lanzola, Gino Roberto Corazza, Antonio Di Sabatino, Coeliac Disease Study Group

Coeliac disease (CD) is a chronic, lifelong, immune-mediated disorder causing villous atrophy in genetically susceptible individuals upon the ingestion of gluten in the diet [1,2]. It has been... more

The effects of sleep improving interventions in medical hospital wards: the WEsleep study - A randomized clinical trial

9 May 2025
Author(s): C.J. de Gans, A.J.G. Meewisse, E.S. van den Ende, M.L. van Zuylen, P.W.B. Nanayakkara, J. Hermanides, D.J. Stenvers, WE Sleep Study Group

Multiple studies indicate that sleep in hospitals is suboptimal.1,2 Disturbed and inadequate sleep occurs in 48 to 77 % of hospitalized patients.3,4 Sleep-disturbing factors in hospitals include... more

Review Article

The role of the senescence-associated secretory phenotype in cardiovascular disease among the elderly

25 August 2025
Author(s): Henry Sutanto, Deasy Fetarayani, M. Rosyid Narendra, Sally Aman Nasution

Aging is a major independent risk factor for cardiovascular disease (CVD), the leading cause of death worldwide, particularly in older adults [1,2]. With global population aging, the burden of age-... more

Earlier Prediction of Cardiovascular Risk with Epicardial Fat Assessment

22 August 2025
Author(s): Giuseppe Calcaterra, Ron T. Varghese, Maurizio Baroni, Alessandro Capucci, Fabio Angeli, Gianluca Iacobellis, Paolo Verdecchia

Obesity is no longer considered a cosmetic problem. The World Health Organisation (WHO) and the European Parliament, as well as many international medical and scientific societies, have recognised... more

Fever and inflammation of unknown origin in the 21st century

20 August 2025
Author(s): Christina Antoniadou, Efstratios Gavriilidis, Petros Chatzopoulos, Maria Gkouliavera, Panagiotis Skendros

Fever of unknown origin (FUO) and inflammation of unknown origin (IUO) are among the most complex and challenging clinical syndromes in Internal Medicine. Internists, by virtue of their broad... more

Management of asymptomatic patients with abnormal liver function tests

9 August 2025
Author(s): Stella Gabeta, George N. Dalekos, Nikolaos K. Gatselis

Liver function tests (LFTs) are regularly included in screening blood panels, making them among the most frequently requested laboratory tests in clinical practice [1–3]. Their widespread use and... more

Charting the future of AL amyloidosis: Diagnostic advancements, prognostic insights, and therapeutic challenges

8 August 2025
Author(s): Xiayin Li, Jiecong Wu, Qing Huang, Wanting Zheng, Lu Huang, Changhao Han, Chunyu Zhang, Zhichun Gan, Yan Xing, Shiren Sun

Light-chain (AL) amyloidosis is a form of plasma cell dyscrasias characterized by deposition of misfolded monoclonal immunoglobulin light chain-derived amyloid fibrils, resulting in abnormal... more

Optimizing PCSK9 inhibitor therapy: Understanding and managing suboptimal LDL-C response in clinical practice

8 August 2025
Author(s): Filippo Giorgio Di Girolamo, Lisa Pellin, Chiara Roni, Gianni Biolo, Gianfranco Sinagra, Enrico Fabris

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality globally[1]. Elevated levels of low-density lipoprotein cholesterol (LDL-C) are a well-recognized... more

The climate crisis in clinical practice: Addressing air pollution, heat, and microplastics

5 August 2025
Author(s): Elizabeth Cerceo

The climate crisis has evolved from a future threat into a present-day health emergency. Rising global temperatures, worsening air pollution, and frequent extreme weather events, all driven by... more

Crystal clear – part I: The role of uric acid in cardiorenal disease

27 July 2025
Author(s): Claudio Borghi, Federica Fogacci, Arrigo FG Cicero

Uric acid (UA), the terminal product of purine catabolism in humans, arises from both endogenous nucleic acid turnover and exogenous sources—particularly diets rich in animal protein and fructose.... more

Effect of sodium-glucose cotransporter-2 inhibitors on skeletal muscle

23 July 2025
Author(s): Claudia Stöllberger, Josef Finsterer, Birke Schneider

Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) are increasingly prescribed for diabetic and nondiabetic patients with and without heart failure (HF) or renal insufficiency [1]. SGLT2i reduce... more

Impact of micro- and nanoplastics on gastrointestinal diseases: Recent advances

23 July 2025
Author(s): Haonan Zhao, Guo Lin, Yuhang Yin, Qinke Wu, Yan Wang, Ning Tang, Xingshun Qi

Plastics are light, durable, low-cost daily necessities used in packaging, medical treatment, electronics, and transportation [1]. Global plastic production has increased from less than two megatons... more

When inflammatory bowel disease meets pregnancy

19 June 2025
Author(s): Shiqing Zhao, Shengpu Zhou, Junmei Wang, Yanyan Shi

Inflammatory bowel disease (IBD) is a group of chronic and relapsing inflammatory conditions of the gastrointestinal tract with two major forms: Crohn’s disease (CD) (affecting any segment of the... more

Point of care ultrasound: focus on evidence for a critical appraisal

16 June 2025
Author(s): E. Ceriani, R. Schiavon, L. La Cava, C. Ruscitti, C. Cogliati

The term point of care ultrasound (POCUS) refers to a sonographic examination directly performed at the patient’s bedside, ideally by the treating physician, to interpret and integrate images into... more

Artificial intelligence and the electrocardiogram: A modern renaissance

20 May 2025
Author(s): Stefano Palermi, Marco Vecchiato, Fu Siong Ng, Zachi Attia, Youngjin Cho, Matteo Anselmino, Gaetano Maria De Ferrari, Andrea Saglietto, on behalf of the International AI-ECG Working Group

The electrocardiogram (ECG) is a fundamental, non-invasive diagnostic tool in cardiology, widely accessible and crucial for assessing the heart's electrical and structural conditions [1].... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness